Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17157119 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed MK0954A-264 Filter Study (0954A-264)(COMPLETED)
Condition: Mild to Severe Hypertension
Interventions: Drug: MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 6 weeks;   Drug: losartan / Duration of Treatment: 6 weeks

Indicates status has not been verified in more than two years